One-Quarter in Ocular HTN Treatment Study Developed Visual Field Loss

FRIDAY, April 23, 2021 -- During long-term follow-up, about one-quarter of participants in the Ocular Hypertension Treatment study developed visual field loss, according to a study published online April 19 in JAMA Ophthalmology. Michael A. Kass,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news